1. Causes of hypereosinophilia in 100 consecutive patients. (18th May 2020) Authors: Moller, Daniel; Tan, Julia; Gauiran, Deonne Thaddeus V.; Medvedev, Nadia; Hudoba, Monika; Carruthers, Mollie N.; Dehghan, Natasha; van den Berghe, Janette; Bruyère, Helene; Chen, Luke Y.C. Journal: European journal of haematology Issue: Volume 105:Number 3(2020) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome. (13th November 2019) Authors: Choi, Charles; Moller, Daniel; Tan, Julia; Dou, Carol; Peterson, Erica A.; Medvedev, Nadia; Dutz, Jan P; Carruthers, Mollie N.; Chen, Luke Y. C. Journal: British journal of haematology Issue: Volume 188:Number 5(2020) Page Start: e68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗